NO20000906L - Farmasøytisk suspensjon omfattende nevirapin hemihydrat - Google Patents

Farmasøytisk suspensjon omfattende nevirapin hemihydrat

Info

Publication number
NO20000906L
NO20000906L NO20000906A NO20000906A NO20000906L NO 20000906 L NO20000906 L NO 20000906L NO 20000906 A NO20000906 A NO 20000906A NO 20000906 A NO20000906 A NO 20000906A NO 20000906 L NO20000906 L NO 20000906L
Authority
NO
Norway
Prior art keywords
pharmaceutical suspension
nevirapine hemihydrate
nevirapine
hemihydrate
pharmaceutical
Prior art date
Application number
NO20000906A
Other languages
English (en)
Other versions
NO20000906D0 (no
NO326226B1 (no
Inventor
Karl Georg Grozinger
Amale A Hawi
Original Assignee
Boehringer Ingelheim Pharma
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=22006658&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=NO20000906(L) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Boehringer Ingelheim Pharma filed Critical Boehringer Ingelheim Pharma
Publication of NO20000906D0 publication Critical patent/NO20000906D0/no
Publication of NO20000906L publication Critical patent/NO20000906L/no
Publication of NO326226B1 publication Critical patent/NO326226B1/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/12—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains three hetero rings
    • C07D471/14—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
    • A61K31/551—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole having two nitrogen atoms, e.g. dilazep
    • A61K31/5513—1,4-Benzodiazepines, e.g. diazepam or clozapine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/18—Antivirals for RNA viruses for HIV

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Virology (AREA)
  • Epidemiology (AREA)
  • Communicable Diseases (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Molecular Biology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • AIDS & HIV (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Steroid Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
NO20000906A 1997-08-25 2000-02-24 Farmasoytisk blanding omfattende nevirapin hemihydrat, samt fremstilling av nevirapin hemihydrat. NO326226B1 (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US5680397P 1997-08-25 1997-08-25
PCT/US1998/016581 WO1999009990A1 (en) 1997-08-25 1998-08-11 Pharmaceutical suspension comprising nevirapine hemihydrate

Publications (3)

Publication Number Publication Date
NO20000906D0 NO20000906D0 (no) 2000-02-24
NO20000906L true NO20000906L (no) 2000-02-24
NO326226B1 NO326226B1 (no) 2008-10-20

Family

ID=22006658

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20000906A NO326226B1 (no) 1997-08-25 2000-02-24 Farmasoytisk blanding omfattende nevirapin hemihydrat, samt fremstilling av nevirapin hemihydrat.

Country Status (38)

Country Link
US (2) US6172059B1 (no)
EP (1) EP1019058B1 (no)
JP (1) JP3472261B2 (no)
KR (1) KR100426516B1 (no)
CN (1) CN1197578C (no)
AR (2) AR016869A1 (no)
AT (1) ATE326971T1 (no)
AU (1) AU742761B2 (no)
BG (1) BG64337B1 (no)
BR (1) BR9811994B1 (no)
CA (1) CA2301646C (no)
CL (1) CL2008003111A1 (no)
CO (1) CO4970742A1 (no)
CY (1) CY1105228T1 (no)
CZ (1) CZ290667B6 (no)
DE (1) DE69834655T2 (no)
DK (1) DK1019058T3 (no)
EG (1) EG24075A (no)
ES (1) ES2265666T3 (no)
HK (1) HK1027975A1 (no)
HR (1) HRP980461B1 (no)
HU (1) HU226063B1 (no)
ID (1) ID21650A (no)
IL (1) IL134185A (no)
MY (1) MY122272A (no)
NO (1) NO326226B1 (no)
NZ (1) NZ503414A (no)
PE (1) PE105799A1 (no)
PL (1) PL192361B1 (no)
PT (1) PT1019058E (no)
RS (1) RS49808B (no)
RU (1) RU2196584C2 (no)
SA (1) SA98190680B1 (no)
TR (1) TR200000490T2 (no)
TW (1) TW450812B (no)
UA (1) UA44370C2 (no)
WO (1) WO1999009990A1 (no)
ZA (1) ZA987623B (no)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2002092095A1 (en) * 2001-05-11 2002-11-21 Boehringer Ingelheim International Gmbh Use of nevirapine to treat or prevent lipid pathology in patients with hiv that is resistant to nevirapine
US20030211159A1 (en) * 2002-04-23 2003-11-13 Boehringer Ingelheim Pharmaceuticals, Inc. Method for reduction of residual organic solvent in carbomer
BRPI0617074A2 (pt) * 2005-08-31 2011-07-12 Cipla Ltd composição farmacêutica, uso de lamivudina, nevirapina e stavudina, uso de stavudina, lamivudina e nevirapina, método para tratar uma infecção viral em um humano, método para preparar uma composição farmacêutica, método para preparar uma forma de dosagem unitária farmacêutica bicamadas e método para preparar uma forma de dosagem unitária farmacêutica tri-camadas
US20110082161A1 (en) * 2008-06-30 2011-04-07 Lieven Elvire Colette Baert Powders for reconstitution
BR112012011095A2 (pt) * 2009-11-10 2015-10-06 Univ Northwest método para aumentar a solubilidade de uma composição inibidora de transcriptase
DE112010004862T5 (de) * 2009-12-17 2012-12-06 North West University Polymorphe Form von Nevirapin und deren Herstellung

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5366972A (en) * 1989-04-20 1994-11-22 Boehringer Ingelheim Pharmaceuticals, Inc. 5,11-dihydro-6H-dipyrido(3,2-B:2',3'-E)(1,4)diazepines and their use in the prevention or treatment of HIV infection
CA2030056C (en) * 1989-11-17 1995-10-17 Karl D. Hargrave 5,11-dihydro-6h-dipyrido[3,2-b:2',3'-e][1,4]diazepines and their use in the prevention or treatment of hiv infection
US5571912A (en) * 1990-10-19 1996-11-05 Boehringer Ingelheim Pharmaceuticals, Inc. Method for the preparation of 5,11-dihydro-6h-dipyrido [3,2-b:2',3'-e][1,4]diazepines
DE4403311C1 (de) * 1994-02-03 1995-04-20 Boehringer Ingelheim Kg Verfahren zur Herstellung von Nevirapine (11-Cyclopropyl-5,11-dihydro-4-methyl-6H-dipyrido[3,2-b:2',3'-e][1,4-diazepin]-6-on)

Also Published As

Publication number Publication date
ZA987623B (en) 2000-03-22
EP1019058A4 (en) 2004-11-10
DE69834655T2 (de) 2006-12-14
AU8777198A (en) 1999-03-16
UA44370C2 (uk) 2002-02-15
CN1268055A (zh) 2000-09-27
HRP980461B1 (en) 2002-08-31
DK1019058T3 (da) 2006-06-12
NO20000906D0 (no) 2000-02-24
CZ2000694A3 (cs) 2000-09-13
IL134185A0 (en) 2001-04-30
CA2301646A1 (en) 1999-03-04
SA98190680B1 (ar) 2006-04-04
ATE326971T1 (de) 2006-06-15
CA2301646C (en) 2008-11-18
BR9811994A (pt) 2000-09-05
NO326226B1 (no) 2008-10-20
ES2265666T3 (es) 2007-02-16
ID21650A (id) 1999-07-08
EG24075A (en) 2008-05-11
DE69834655D1 (de) 2006-06-29
EP1019058B1 (en) 2006-05-24
TW450812B (en) 2001-08-21
CL2008003111A1 (es) 2009-09-11
US6172059B1 (en) 2001-01-09
HUP0003093A2 (hu) 2001-08-28
JP2001513564A (ja) 2001-09-04
CO4970742A1 (es) 2000-11-07
IL134185A (en) 2005-11-20
PT1019058E (pt) 2006-08-31
BG64337B1 (bg) 2004-10-29
KR100426516B1 (ko) 2004-04-13
WO1999009990A1 (en) 1999-03-04
CY1105228T1 (el) 2010-03-03
HK1027975A1 (en) 2001-02-02
YU9800A (sh) 2001-12-26
PL192361B1 (pl) 2006-10-31
KR20010023257A (ko) 2001-03-26
BR9811994B1 (pt) 2013-11-19
RU2196584C2 (ru) 2003-01-20
JP3472261B2 (ja) 2003-12-02
AU742761B2 (en) 2002-01-10
HRP980461A2 (en) 1999-06-30
BG104133A (en) 2000-08-31
NZ503414A (en) 2002-11-26
CN1197578C (zh) 2005-04-20
MY122272A (en) 2006-04-29
CZ290667B6 (cs) 2002-09-11
PE105799A1 (es) 1999-11-16
PL338828A1 (en) 2000-11-20
AR016869A1 (es) 2001-08-01
HU226063B1 (hu) 2008-04-28
US6255481B1 (en) 2001-07-03
EP1019058A1 (en) 2000-07-19
AR083451A2 (es) 2013-02-27
TR200000490T2 (tr) 2000-08-21
RS49808B (sr) 2008-08-07

Similar Documents

Publication Publication Date Title
NO20001776D0 (no) Medikamenter
IS5245A (is) Lyfjablanda úr ómeprasól
IS4974A (is) Lyfjasamsetning á þrýstingsúðaformi
NO980546D0 (no) Farmasöytiske midler
DK1466615T3 (da) Farmaceutisk præparat
IS5331A (is) Ný lyfjablanda
ID29294A (id) Komposisi farmasi
DE69705017D1 (de) Medikamente bindendes Protein
ID25857A (id) Komposisi farmasi
DE69837507D1 (de) Humanes Hedgehog-Protein
NO20000906L (no) Farmasøytisk suspensjon omfattende nevirapin hemihydrat
FR2767673B1 (fr) Prothese uretrale
DE59803628D1 (de) Modulare brücke
ID23531A (id) Komposisi farmasi
ID23663A (id) Persiapan kaprolaktam
FI3862U1 (fi) Geelimuotoinen farmaseuttinen valmiste
DE29618094U1 (de) Pharmazeutisches Präparat
DE29719198U1 (de) Flavono/Flavonoid-Zubereitung
FI974129A (fi) Apuväline
DK114597A (da) Modulophæng
KR970058612U (ko) 스터디 캡슐
BR1100755A (pt) composição farmacêutica
ID21180A (id) Senyawa-senyawa farmasi
FI974374A0 (fi) Apparat traevarorkraan foer faestaenden fordon
DK0889860T3 (da) Cementadditiver

Legal Events

Date Code Title Description
MM1K Lapsed by not paying the annual fees